Related references
Note: Only part of the references are listed.Aortic Aneurysms and Dissections Series
Ying H. Shen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Impaired vascular smooth muscle cell force-generating capacity and phenotypic deregulation in Marfan Syndrome mice
Patricia Nolasco et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli et al.
PLOS ONE (2020)
Aortic Disease-in-a-Dish: Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling
Hongorzul Davaapil et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Marfan syndrome: A therapeutic challenge for long-term care
A. H. Wagner et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Specificity, versatility, and control of TGF-β family signaling
Rik Derynck et al.
SCIENCE SIGNALING (2019)
Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome A Review
Marion A. Hofmann Bowman et al.
JAMA CARDIOLOGY (2019)
Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family
Sun Kyung Kim et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections Old Controversies and New Opportunities
Dianna M. Milewicz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGFβ signaling and cell stemness
Francesco Ramirez et al.
MATRIX BIOLOGY (2018)
Betaglycan (TGFBR3) up-regulation correlates with increased TGF-β signaling in Marfan patient fibroblasts in vitro
Menno Evert Groeneveld et al.
CARDIOVASCULAR PATHOLOGY (2018)
From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta
Jean-Baptiste Michel et al.
CARDIOVASCULAR RESEARCH (2018)
Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its Solution
Erica Rurali et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Mechanical barriers and transforming growth factor beta inhibitor on epidural fibrosis in a rabbit laminectomy model
Juan N. Albinana-Cunningham et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2018)
TGF-beta family co-receptor function and signaling
Joachim Nickel et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Recapitulating and Correcting Marfan Syndrome in a Cellular Model
Jung Woo Park et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm
Christine Gibson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model
Aleksandra Mas-Stachurska et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor beta Signaling
Hao Wei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome
Matthew Dale et al.
PLOS ONE (2017)
Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells
Eithne Margaret Maguire et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Gabriel Gallo-Oller et al.
CANCER LETTERS (2016)
FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders
Lynn Y. Sakai et al.
GENE (2016)
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells
Jose Medina-Echeverz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Julie De Backer et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome
Lior Zilberberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Echocardiographic versus Histologic Findings in Marfan Syndrome
Xiaoyan Gu et al.
TEXAS HEART INSTITUTE JOURNAL (2015)
Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes
J. R. Cook et al.
CLINICAL GENETICS (2015)
Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome
Yskert Von Kodolitsch et al.
APPLICATION OF CLINICAL GENETICS (2015)
Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis
Wei Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Harnessing High Density Lipoproteins to Block Transforming Growth Factor Beta and to Inhibit the Growth of Liver Tumor Metastases
Jose Medina-Echeverz et al.
PLOS ONE (2014)
Dysfunctional Mechanosensing in Aneurysms
Jay D. Humphrey et al.
SCIENCE (2014)
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
R. Jude Samulski et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
A Synthetic Peptide from Transforming Growth Factor-β1 Type III Receptor Inhibits NADPH Oxidase and Prevents Oxidative Stress in the Kidney of Spontaneously Hypertensive Rats
Ana Baltanas et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Perturbations of mechanotransduction and aneurysm formation in heritable aortopathies
Richmond W. Jeremy et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Matrix-dependent perturbation of TGFβ signaling and disease
Jefferson J. Doyle et al.
FEBS LETTERS (2012)
TGFβ Signaling and Cardiovascular Diseases
Evangelia Pardali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Blockade of TGF-β 1 Signalling Inhibits Cardiac NADPH Oxidase Overactivity in Hypertensive Rats
Jose Luis Miguel-Carrasco et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis
Laura Arribillaga et al.
CYTOKINE (2011)
Betaglycan: A multifunctional accessory
Maree Bilandzic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions
Harry C. Dietz
JOURNAL OF CLINICAL INVESTIGATION (2010)
TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice
Yu Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The revised Ghent nosology for the Marfan syndrome
Bart L. Loeys et al.
JOURNAL OF MEDICAL GENETICS (2010)
Marfan syndrome. Part 1: pathophysiology and diagnosis
Victoria Canadas et al.
NATURE REVIEWS CARDIOLOGY (2010)
Marfan syndrome. Part 2: treatment and management of patients
Victoria Canadas et al.
NATURE REVIEWS CARDIOLOGY (2010)
Betaglycan has Two Independent Domains Required for High Affinity TGF-β Binding: Proteolytic Cleavage Separates the Domains and Inactivates the Neutralizing Activity of the Soluble Receptor
Valentin Mendoza et al.
BIOCHEMISTRY (2009)
A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Nerea Hermida et al.
CARDIOVASCULAR RESEARCH (2009)
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
Diana Llopiz et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Transforming Growth Factor-beta Signaling in Thoracic Aortic Aneurysm Development: A Paradox in Pathogenesis
Jeffrey A. Jones et al.
JOURNAL OF VASCULAR RESEARCH (2009)
Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library
Javier Dotor et al.
CYTOKINE (2007)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Use of the transforming growth factor-β1 inhibitor peptide in periprosthetic capsular fibrosis:: Experimental model with tetraglycerol dipalmitate
R Ruiz-de-Erenchun et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Adeno-associated virus (AAV)-7 and-8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation
L Denby et al.
GENE THERAPY (2005)
Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis
B Santiago et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice
H Nakai et al.
JOURNAL OF VIROLOGY (2005)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury
IJ Ezquerro et al.
CYTOKINE (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
Share Paper
